Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-045859
Filing Date
2013-08-14
Accepted
2013-08-14 17:29:34
Documents
13
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v351168_10q.htm 10-Q 465627
2 EXHIBIT 10.12 v351168_ex10-12.htm EX-10.12 8425
3 EXHIBIT 10.15 v351168_ex10-15.htm EX-10.15 5377
4 EXHIBIT 31.1 v351168_ex31-1.htm EX-31.1 10297
5 EXHIBIT 31.2 v351168_ex31-2.htm EX-31.2 29250
6 EXHIBIT 32.1 v351168_ex32-1.htm EX-32.1 4648
7 EXHIBIT 32.2 v351168_ex32-2.htm EX-32.2 5937
  Complete submission text file 0001144204-13-045859.txt   7256161

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT eltp-20130630.xml EX-101.INS 817010
9 XBRL TAXONOMY EXTENSION SCHEMA eltp-20130630.xsd EX-101.SCH 68252
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eltp-20130630_cal.xml EX-101.CAL 16681
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eltp-20130630_def.xml EX-101.DEF 328053
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE eltp-20130630_lab.xml EX-101.LAB 326817
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eltp-20130630_pre.xml EX-101.PRE 383288
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15697 | Film No.: 131038019
SIC: 2834 Pharmaceutical Preparations